Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase (HMGCR) Immune-Mediated Necrotizing Myopathy With Subsequent Diagnosis of Mantle Cell Lymphoma
Cureus · 01.05.2026
DOI: 10.7759/cureus.108086 ↗Kurz gefasst
Fallbericht in der Zeitschrift Cureus, erschienen am 01.05.2026. Verfasst von Chuchu Zhao und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, NYC Health + Hospitals/Queens, Icahn School of Medicine at Mount Sinai, New York, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, NYC Health + Hospitals/Queens, Icahn School of Medicine at Mount Sinai, New York, USA.
- Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, USA.
Zitieren
APA
Zhao, C., Duffield, A., & Toz, B. (2026). Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase (HMGCR) Immune-Mediated Necrotizing Myopathy With Subsequent Diagnosis of Mantle Cell Lymphoma. Cureus. https://doi.org/10.7759/cureus.108086
Vancouver
Zhao C, Duffield A, Toz B. Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase (HMGCR) Immune-Mediated Necrotizing Myopathy With Subsequent Diagnosis of Mantle Cell Lymphoma. Cureus. 2026. doi:10.7759/cureus.108086
BibTeX
@article{Zhao2026,
author = {Zhao, Chuchu and Duffield, Amy and Toz, Bahtiyar},
title = {Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase (HMGCR) Immune-Mediated Necrotizing Myopathy With Subsequent Diagnosis of Mantle Cell Lymphoma},
journal = {Cureus},
year = {2026},
doi = {10.7759/cureus.108086}
}
EUVIMED